Anticancer Hospital of Thessaloniki THEAGENIO

Thessaloniki 546 39

0 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Pancreatic Cancer

Studies at this site

• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed